| .
Introduction |
.
. Enzymes assume many conformations. However, the native structure is the most energetically preferred. Any alteration to the native structure may lead to loss of an enzyme's activity, a phenomenon called denaturation. Since the native structure is maintained mostly by the weak forces of hydrogen bonding and electrostatic and hydrophobic interactions, enzymes can easily be denatured during purification, storage, transport and use. A novel method uses cyclodextrins (CDs) without detergents to renature or refold a solution of denatured, inactive enzymes. The technology is expected to provide enzymes in higher specific activity. Research Corporation Technologies (RCT) applied for patent protection and manages the technology on behalf of Central Michigan University and the inventors, Drs. Ajit Sharma and Nadarajah Karuppiah. RCT
seeks to commercialize the method through exclusive licenses by enzyme
type. Examples of economically significant enzymes produced in medium-to-high
purity are lactase, glucose oxidase, penicillin G acylase and thermolysin.
|
||||||||||
| Inventive
concept
|
CDs
are water-soluble, doughnut-shaped molecules that possess a water-like
outer surface and an oil-like inner surface. Some amino-acid side chains
(residues) of enzymes have affinities for the inner surface of CDs. Once
an enzyme is completely unfolded into a nearly linear chain of amino acids,
these residues contact the inner surface of the CDs. The remaining amino
acids interact with the water-like properties of the CD's outer lip; this
causes the enzyme to collapse upon itself, facilitating the natural folding
mechanism.
No
chemical bond forms between the enzyme and the CD, so the interaction is
reproduced in solution, and over time the enzyme equilibrates into its
low-energy active state.
|
||||||||||
| Benefits | Cyclodextrins
provide four main advantages over in-vitro folding aids or renaturants
such as sugars, surfactants, polyethylene glycol and polyamino acids:
|
||||||||||
| Typical procedure | A
sample containing inactive enzyme is denatured at a high concentration
(50 mg/mL) using denaturants such as guanidinium chloride or urea. The
enzyme can be renatured by rapid dilution into a solution of 5-10% buffered
a-CD.
Alternatively, active enzyme can be obtained by dialysis of the denatured solution against a 5-10% buffered a-CD solution. The guanidinium chloride or urea in the spent CD solution can be removed by filtration, thereby recycling the CD solution. Finished
enzyme purity can be monitored, since literature references have reported
common HPLC methods to detect cyclodextrins in protein matrices at sensitivities
of <10 ppb.
|
||||||||||
| Refolding of inactive enzyme in commercial samples | The
renaturation of commercially available carbonic anhydrase provides an impressive
demonstration of this technology. The inventors denatured the sample, then
renatured it to 144% of the original activity using CDs (Figure 1).
TOP |
||||||||||
| Refolding with a-CD compared to PEG | The
refolding of a-amylase
with a-CD
was compared with a well-known protein-folding aid, polyethylene glycol
(3% PEG in 50 mM Tris sulfate buffer, pH 8.5). Renaturation was performed
at a protein concentration of 0.5 mg/mL using 50 mM Tris sulfate buffer,
pH 8.5 (Figure 2).
The unoptimized results demonstrate that a-CD is a much better folding agent than PEG. Similar results were obtained with carbonic anhydrase. TOP |
||||||||||
| High protein concentrations during refolding means lower processing costs | Processing
costs to renature enzymes are minimized sine CD renaturation can be performed
at high enzyme concentrations. Smaller process volumes are required to
practice the technology compared to using other refolding aids. This results
in lower costs for capital equipment, labor and raw materials.
To illustrate, a commercial sample of a-amylase was renatured at variable enzyme concentrations with and without ? -CD (Figure 3). Higher enzyme activity was achieved at higher enzyme concentrations. The graph shows the recovery of native protein (U/L) obtained after 2 hr refolding with renaturation buffer (0 M Tris-Cl, pH 8.0) with and without a-CD (10%) at room temperature. Protein concentration during refolding was 0.0125 to 0.2 mg/mL. An
explanation for obtaining higher renatured activity at higher enzyme concentrations
may be provided by the results of the experiment described below.
![]()
When denatured CAB in GuHCI was rapidly diluted with 50 mM Tris-sulfate buffer at pH 8.5, aggregation was observed immediately and monitored by light scattering at 400nm. Aggregation increased with time and then stabilized after about 5 min. When
the denatured protein was renatured in the presence of CDs under the same
conditions, light scattering due to aggregation was significantly reduced.
TOP |
||||||||||
| Reactivation kinetics in the presence of cyclodextrins | The
CD-assisted reactivation of enzymes is a relatively fast process. The reaction
kinetics observed in the reactivation of carbonic anhydrase (CAB) are typical
for this technology.
Reactivation
kinetics of CAB at aggregating conditions in the presence of a, ,6 and
y CDs and no CDs are shown in Figure 5. Alpha CD at l00mM provided over
80% recovery in less than an hour and then gradually reached a plateau
of greater than 90% recovery within five hours of renaturation.
![]() Recovery of esterase activity (compared to the native enzyme) was then measured as a function of time after dilution. TOP |
||||||||||
| Effect
of
temperature and pH on cyclodextrin-assisted enzyme refolding |
No
complicated renaturation process conditions are necessary. Neutral or alkaline
pH and ambient temperature can be used. Figures 6 and 7 demonstrate the
effect of temperature and pH on the CD-assisted refolding of carbonic anhydrase.
Optimal yield of active protein was observed between 25°C and 37°C
and between pH 7-9.
|
||||||||||
| ABOUT RCT | Research
Corporation Technologies is the premier provider of technology transfer
services to North American universities. Based on revenues and distributions,
RCT is the world's most successful independent technology management organization.
RCT identifies, appraises, protects and commercializes inventions developed at research organizations. Its scientists, lawyers, and experts in marketing, communications, and information retrieval work with industrial contacts to bring inventions to market. RCT licenses technologies, invests in invention development, forms new companies and participates in joint ventures. Project
revenues for 1994 totaled $59.8 million, and RCT distributed $38.2 million
to inventors and institutions. The company appraised 671 invention disclosures
in 1994 from 144 research institutions.
|